Shoulder Innovations (NYSE:SI) Announces Earnings Results, Misses Estimates By $63.95 EPS

Key Points

• Shoulder Innovations reported a quarterly loss of ($64.47) earnings per share, reflecting challenges in its financial performance.
• The company's stock saw a 7.9% increase, with a current price of $16.03 and a market capitalization of approximately $244.14 million.
• Analysts are optimistic, with multiple firms issuing buy ratings and a consensus price target of $19.60 for the stock.

Shoulder Innovations (NYSE:SI - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($64.47) EPS for the quarter, missing the consensus estimate of ($0.52) by ($63.95), Zacks reports. The company had revenue of $11.01 million during the quarter, compared to analyst estimates of $11.00 million. Shoulder Innovations updated its FY 2025 guidance to EPS.

Shoulder Innovations Price Performance

Shares of SI traded up $0.72 during midday trading on Friday, hitting $15.72. The stock had a trading volume of 143,494 shares, compared to its average volume of 143,670. The company has a market capitalization of $239.42 million and a price-to-earnings ratio of -0.52. Shoulder Innovations has a twelve month low of $11.75 and a twelve month high of $17.94.

Insiders Place Their Bets

In related news, Director Michael A. Carusi bought 266,666 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were acquired at an average price of $15.00 per share, with a total value of $3,999,990.00. Following the completion of the transaction, the director owned 1,885,136 shares in the company, valued at $28,277,040. The trade was a 16.48% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Geoffrey B. Pardo bought 100,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was bought at an average cost of $15.00 per share, for a total transaction of $1,500,000.00. Following the transaction, the director owned 2,380,482 shares of the company's stock, valued at $35,707,230. The trade was a 4.39% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 778,382 shares of company stock valued at $11,675,730 in the last quarter. 1.71% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Jefferies Financial Group assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They set a "buy" rating and a $19.00 price objective on the stock. Piper Sandler assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They issued an "overweight" rating and a $18.00 price target on the stock. Zacks Research raised Shoulder Innovations to a "hold" rating in a research note on Tuesday, August 26th. BTIG Research reissued a "buy" rating and issued a $23.00 price target on shares of Shoulder Innovations in a research note on Tuesday, September 9th. Finally, Wall Street Zen raised Shoulder Innovations from a "sell" rating to a "hold" rating in a research note on Saturday. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $19.60.

Shoulder Innovations Company Profile

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.